Authors: Aoki, KR

Citation: Kr. Aoki, Pharmacology and immunology of botulinum toxin serotypes, J NEUROL, 248, 2001, pp. S3-S10

Authors: Aoki, KR

Citation: Kr. Aoki, A comparison of the safety margins of botulinum neurotoxin serotypes A, B,and F in mice, TOXICON, 39(12), 2001, pp. 1815-1820

Authors: Graham, HK Aoki, KR Autti-Ramo, I Boyd, RN Delgado, MR Gaebler-Spira, DJ Gormley, ME Guyer, BM Heinen, F Holton, AF Matthews, D Molenaers, G Motta, F Ruiz, PJG Wissel, J

Citation: Hk. Graham et al., Recommendations for the use of botulinum toxin type A in the management ofcerebral palsy, GAIT POSTUR, 11(1), 2000, pp. 67-79

Authors: Aoki, KR

Citation: Kr. Aoki, Preclinical update on BOTOX (R) (botulinum toxin type A)-purified neurotoxin complex relative to other botulinum neurotoxin preparations, EUR J NEUR, 6, 1999, pp. S3-S10

Authors: de Paiva, A Meunier, FA Molgo, J Aoki, KR Dolly, JO

Citation: A. De Paiva et al., Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals, P NAS US, 96(6), 1999, pp. 3200-3205